InsidersTradesSigma
Follow the 삼양바이오팜 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 삼양바이오팜 has recorded 1 insider filings. Market capitalisation: €282.6bn. The latest transaction was reported on 4 March 2026 (Other). Among the most active insiders: 김윤. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Samyang Biopharm 是一家在健康和制药领域运营的公司，在 XKRX 市场上市。它专注于创新医药产品的开发。